Role of the androgen signaling axis in genitourinary malignancies

Area of Science:

• Oncology
• Molecular Biology
• Urology

Background:

• Genitourinary malignancies, including prostate, renal, and bladder cancers, have high mortality rates, particularly in advanced stages.
• The androgen signaling axis and androgen receptor (AR) are critical in prostate cancer, and their roles in renal cell carcinoma (RCC) and bladder cancer are increasingly recognized.

Purpose of the Study:

• To review current research on the androgen signaling axis in genitourinary malignancies.
• To explore the therapeutic potential of targeting the AR pathway in these cancers.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of the role of androgen signaling in prostate, renal, and bladder cancer development and progression.

Main Results:

• The androgen receptor (AR) plays a significant role in the pathogenesis of genitourinary cancers.
• Emerging evidence highlights the relevance of AR signaling in renal cell carcinoma and bladder cancer, beyond its established role in prostate cancer.

Conclusions:

• Targeting the androgen signaling axis represents a promising therapeutic strategy for genitourinary malignancies.
• Further research into AR pathways can expand treatment options for patients with advanced prostate, renal, and bladder cancers.